LisaMelanieFordMD

PubMed

• Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
  Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Bar...> ;JAMA. 2015-05-19
• 10 citations
  Pharmacokinetic interactions between topiramate and pioglitazone and metformin.
  Prasarn Manitpisitkul, Christopher R. Curtin, Kevin Shalayda, Shean-Sheng Wang, Lisa Ford, Donald Heald> ;Epilepsy Research. 2014 Nov 1
• 5 citations
  Pharmacokinetic interactions between topiramate and diltiazem, hydrochlorothiazide, or propranolol
  Prasarn Manitpisitkul, Christopher R. Curtin, Kevin Shalayda, Shean-Sheng Wang, Lisa Ford, Donald Heald> ;Clinical pharmacology in drug development. 2014 Sep 1
• 8 citations
  Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment
  Prasarn Manitpisitkul, Christopher R. Curtin, Kevin Shalayda, Shean-Sheng Wang, Lisa Ford, Donald Heald> ;Epilepsy Research. 2014 Jul 1
• 12 citations
  Topiramate monotherapy use in women with and without epilepsy: Pregnancy and neonatal outcomes
  Ruby Castilla-Puentes, Lisa Ford, Lewis Manera, Robert F. Kwarta, Steve Ascher, Qin Li> ;Epilepsy Research. 2014 May 1
• 6 citations
  Evaluation of JNJ-26489112 in patients with photosensitive epilepsy: a placebo-controlled, exploratory study.
  Nicholas A. Di Prospero, Jay J. Gambale, Gahan Pandina, Lisa Ford, Suzette Girgis, John A. Moyer, Liwen Xi, Jeffrey S. Nye, Dorothée G.A. Kasteleijn-Nolst Trenité> ;Epilepsy Research. 2014 May 1
• 11 citations
  Efficacy and safety of carisbamate in patients with diabetic neuropathy or postherpetic neuralgia: results from 3 randomized, double-blind placebo-controlled trials.
  Timothy Smith, Allitia DiBernardo, Yingqi Shi, Michael J. Todd, H. Robert Brashear, Lisa Ford> ;Pain Practice. 2014 Apr 1
• Implications of retinal effects observed in chronic toxicity studies on the clinical development of a CNS-active drug candidate.
  Eichenbaum, G.,Zhou, J.,Kelley, M. F.,Roosen, W.,Costa-Giomi, P.,Louden, C.,Diprospero, N.,Pandina, G.,Singh, J.,Ford, L.,Moyer, J.,Nork, T. M.,Ver Hoeve, J. N.,Aguirr...> ;Regul. Toxicol. Pharmacol.. 2014 Apr 01
• 3 citations
  An Open-Label Drug–Drug Interaction Study of the Steady-State Pharmacokinetics of Topiramate and Glyburide in Patients with Type 2 Diabetes Mellitus
  Prasarn Manitpisitkul, Christopher R. Curtin, Kevin Shalayda, Shean-Sheng Wang, Lisa Ford, Donald Heald> ;Clinical Drug Investigation. 2013 Oct 17
• 4 citations
  Effect of Topiramate Monotherapy on Height in Newly Diagnosed Children With Epilepsy
  Lisa Ford, Michael J. Todd, Elena Polverejan> ;Pediatric Neurology. 2013 May 1
• 14 citations
  Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
  Prasarn Manitpisitkul, Kevin Shalayda, Michael J. Todd, Shean S. Wang, Seth Ness, Lisa Ford> ;Epilepsia. 2013 Jan 1
• 4 citations
  Adaptive Behavior Outcomes in Infants Treated With Adjunctive Topiramate
  Seth Ness, Michael J. Todd, Steven Wang, Marielle Eerdekens, Jeffrey S. Nye, Lisa Ford> ;Pediatric Neurology. 2012 Jun 1
• 26 citations
  Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
  Ihab G. Girgis, Partha Nandy, Jeffrey S. Nye, Lisa Ford, Surya Mohanty, Steven Wang, Stefan Ochalski, Mariëlle Eerdekens, Eugene Cox> ;Epilepsia. 2010 Oct 1
• 30 citations
  Cognitive effects of topiramate in migraine patients aged 12 through 17 years.
  Gahan J. Pandina, Seth Ness, Elena Polverejan, Eric Yuen, Mariëlle Eerdekens, Robert M. Bilder, Lisa Ford> ;Pediatric Neurology. 2010 Mar 1
• 13 citations
  Neurological and psychopathological sequelae associated with a lifetime intake of 40,000 ecstasy tablets.
  Christos Kouimtsidis, Fabrizio Schifano, Tim Sharp, Lisa Ford, Justin Robinson, Colm Magee> ;Psychosomatics. 2006 Jan 1
• 7 citations
  Results of N-methyl-D-aspartate antagonists in perinatal cerebral asphyxia therapy.
  Lisa M. Ford> ;Pediatric Neurology. 1990 Nov 1
• 25 citations
  Neurologic Status and Intracranial Hemorrhage in Very-Low-Birth-Weight Preterm Infants: Outcome at 1 Year and 5 Years
  Lisa M. Ford, Jean J. Steichen, Paula A Steichen Asch, Diane S. Babcock, M H Fogelson> ;JAMA Pediatrics. 1989 Oct 1
• 44 citations
  The topography of MK-801-induced locomotor patterns in rats.
  Lisa M. Ford, Andrew B. Norman, Paul R. Sanberg> ;Physiology &amp; Behavior. 1989 Oct 1
• 73 citations
  MK-801 Prevents Hippocampal Neurodegeneration in Neonatal Hypoxic-Ischemic Rats
  Lisa M. Ford, Paul R. Sanberg, Andrew B. Norman, M H Fogelson> ;JAMA Neurology. 1989 Oct 1
• Very-low-birth-weight, preterm infants with or without intracranial hemorrhage. Neurologic, cognitive and cranial MRI correlations at 4-8-year follow-up.
  Ford LM, Han BK, Steichen J, Babcock D, Fogelson H> ;Clin Pediatr (Phila). 1989-07-01
• Cerebral hemiatrophy--correlation of human with animal experimental data.
  Ford L, de Courten-Myers GM, Mandybur T, Myers RE> ;Pediatr Neurosci. 1988-01-01
• Mr. Jones from head to toe.
  Ford L> ;Can Nurse. 1976-11-01
• Inactivation of oxidative and phosphorylative systems in mitochondria by preincubation with phosphate and other ions.
  HUNTER FE, FORD L> ;J. Biol. Chem.. 1955-09-01
• Nitrite formation by enzymatic reaction of mannitol hexanitrate with glutathione.
  HUNTER FE, FORD L> ;J. Pharmacol. Exp. Ther.. 1955-02-01
• Join now to see all